Brief: Shanghai Haohai Biological Technology's Controlling Shareholder Investigated For Suspected Insider Trading
May 7 (Reuters) - Shanghai Haohai Biological Technology Co Ltd 688366.SS: SAYS JIANG WEI, ONE OF CO'S CONTROLLING SHAREHOLDERS, ACTUAL CONTROLLERS, IS INVESTIGATED BY SECURITIES REGULATOR FOR SUSPECTED INSIDER TRADING Source text Further company coverage: 688366.SS (Reporting by Beijing Newsroom) ((yukun.zhang@thomsonreuters.com;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.